Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

ecancermedicalscience

Submit article
Articles
Editorials
Special issues
Author interviews
https://doi.org/10.3332/ecancer.2008.121
Abstract | Full Article | PDF

Short Communication

Azacitidine prolongs overall survival and reduces infections and hospitalisations in patients with WHO-defined acute myeloid leukaemia compared with conventional care regimens: an update

10 Dec 2008
P Fenaux, GJ Mufti, E Hellström-Lindberg, V Santini, N Gattermann, G Sanz, AF List, SD Gore, JF Seymour, J Backstrom, L Zimmerman, D McKenzie, CL Beach, LB Silverman

Azacitidine (AZA), as demonstrated in the phase III trial (AZA-001), is the first MDS treatment to significantly prolong overall survival (OS) in higher risk MDS pts ((2007) Blood 110 817). Approximately, one-third of the patients (pts) enrolled in AZA-001 were FAB RAEB-T (¡Ý20¨C30% blasts) and now meet the WHO criteria for acute myeloid leukaemia (AML) ((1999) Blood 17 3835). Considering the poor prognosis (median survival <1 year) and the poor response to chemotherapy in these pts, this sub-group analysis evaluated the effects of AZA versus conventional care regimens (CCR) on OS and on response rates in pts with WHO AML.

Related Articles

2155-the-influence-of-caregiver-type-on-isolation-distress-and-care-satisfaction-in-hematopoietic-stem-cell-transplant-patients-the-mediating-role-of-relationships
Anjali Rathee, Priyanshi Dixit, Surya Kant Tiwari, Mukul Aggarwal, Pradeep Kumar, Rishi Dhawan, Richa Chauhan, Jasmita Dass, Ganesh Kumar Vishwanathan, Tulika Seth, Manoranjan Mahapatra
2153-breaking-barriers-in-cancer-pain-management-a-report-from-the-national-week-against-cancer-pain-in-argentina-2025
Ariel Cherro, Laura Aresca, María Susana Ciruzzi, Alejo Agranatti, María Fernanda Montaña, Cynthia Frahne, Jaqueline Cimerman
2150-safety-of-immune-checkpoint-inhibitors-in-a-diverse-patient-population-a-single-institution-experience
Grace M Ferri*, John F Murphy*, Akash Oza*, Alexander J B Bulteel, Wafaa Abbasi, Rachel Anderson, Mehmed Taha Dinc, Eva Gaufberg, Kayra Cengiz, Sainikhil Sontha, Janice Weinberg, Patrick Kurpaska, Yashvin Onkarappa Mangala, Matthew Kulke, Umit Tapan
2145-survival-analysis-of-cancer-patients-a-case-study-of-cape-coast-teaching-hospital-ghana
Mahama Jato Asuma, Akoto Yaw Omari Sasu, Alhassan Faisal, Akulibile James, Addae Bernard Mensah
2143-primary-healthcare-utilisation-and-associated-factors-among-post-treatment-prostate-cancer-survivors-in-tanzania-a-cross-sectional-study
Rabson R Nakey, Gideon P Kwesigabo, Monica C Shabani, Yemela K Ndibalema, Aurelia J Temba
2137-nutritional-status-at-diagnosis-and-follow-up-and-its-impact-on-short-term-clinical-outcome-in-children-with-cancer-a-real-world-report-from-india
Rajul M Gala, Maya Prasad Shyam Srinivasan, Venkata Rama Mohan Gollamudi, Chetan Dhamne, Nirmalya Roy Moulik, Badira Parambil, Akanksha Chichra, Gaurav Narula, Girish Chinnaswamy

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation